688246.SH
嘉和美康
SSE · Healthcare · Medical - Distribution · CN
CNY 17.06
−2.01%Year over year
Reported trailing growth
- Revenue
- -32.1%
- EBITDA
- —
- EBIT
- -11.7%
- EPS
- —
- Free cash flow
- +29.0%
- Operating cash flow
- +16.0%
Forward estimates
Based on analyst estimates
- Revenue
- -14.2%
- EBITDA
- +164.4%
- EPS
- +151.2%
Three-year CAGR
- Revenue
- -17.4%
- EBITDA
- -15.0%
- EBIT
- -28.7%
- Net income
- +2.2%
- EPS
- —
- Free cash flow
- +12.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026